Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial.

Authors:
Lee CJ; Kang WC; Ihm SH; Sohn IS; Woo JS and 13 more

Journal:
J Clin Hypertens (Greenwich)

Publication Year: 2024

DOI:
10.1111/jch.14778

PMCID:
PMC10918710

PMID:
38319595

View on PubMed View on PMC View Publisher
Journal Information

Journal Title: J Clin Hypertens (Greenwich)

Detailed journal information not available.

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors have indicated that they have no conflicts of interest regarding the content of this article."

Evidence found in paper:

"This study was sponsored by Chong Kun Dang Pharmaceutical Company, Seoul, Korea."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025